Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lityńska A[au]:

Diversified β-2-adrenergic Receptor Expression and Action in Melanoma Cells. Janik ME et al. Anticancer Res. (2017)

Towards understanding the role of sialylation in melanoma progression. Kolasińska E et al. Acta Biochim Pol. (2016)

Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells. Pokrywka M et al. Cell Biol Int. (2016)

Search results

Items: 1 to 50 of 79

1.

An Insight into the Proteome of Uveal Melanoma-Derived Ectosomes Reveals the Presence of Potentially Useful Biomarkers.

Surman M, Hoja-Łukowicz D, Szwed S, Kędracka-Krok S, Jankowska U, Kurtyka M, Drożdż A, Lityńska A, Stępień E, Przybyło M.

Int J Mol Sci. 2019 Aug 2;20(15). pii: E3789. doi: 10.3390/ijms20153789.

2.

Contribution of sialic acids to integrin α5β1 functioning in melanoma cells.

Kolasińska E, Janik ME, Lityńska A, Przybyło M.

Adv Med Sci. 2019 Mar 4;64(2):267-273. doi: 10.1016/j.advms.2019.02.002. [Epub ahead of print]

PMID:
30844664
3.

Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers.

Hoja-Łukowicz D, Szwed S, Laidler P, Lityńska A.

Biochimie. 2018 Aug;151:14-26. doi: 10.1016/j.biochi.2018.05.010. Epub 2018 May 24.

PMID:
29802864
4.

The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.

Link-Lenczowski P, Bubka M, Balog CIA, Koeleman CAM, Butters TD, Wuhrer M, Lityńska A.

Glycoconj J. 2018 Apr;35(2):217-231. doi: 10.1007/s10719-018-9814-y. Epub 2018 Mar 3.

5.

Diversified β-2-adrenergic Receptor Expression and Action in Melanoma Cells.

Janik ME, Szlęzak D, Surman M, Gołas A, Lityńska A, Przybyło M.

Anticancer Res. 2017 Jun;37(6):3025-3033.

PMID:
28551641
6.

Towards understanding the role of sialylation in melanoma progression.

Kolasińska E, Przybyło M, Janik M, Lityńska A.

Acta Biochim Pol. 2016;63(3):533-41. doi: 10.18388/abp.2015_1221. Epub 2016 Jul 30.

7.

Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells.

Pokrywka M, Bubka M, Janik M, Pocheć E, Hoja-Łukowicz D, Lityńska A.

Cell Biol Int. 2016 Apr;40(4):428-38. doi: 10.1002/cbin.10582. Epub 2016 Feb 18.

PMID:
26800112
8.

β1,6-branched complex-type N-glycans affect FAK signaling in metastatic melanoma cells.

Pocheć E, Ząbczyńska M, Bubka M, Homa J, Lityńska A.

Cancer Invest. 2016;34(1):45-56. doi: 10.3109/07357907.2015.1102928. Epub 2016 Jan 8.

PMID:
26745022
9.

Expression of Caveolin-1 in Human Cutaneous and Uveal Melanoma Cells.

Belkot K, Bubka M, Litynska A.

Folia Biol (Krakow). 2016;64(3):145-151.

PMID:
29847075
10.

Immunosuppressive drugs affect high-mannose/hybrid N-glycans on human allostimulated leukocytes.

Pocheć E, Bocian K, Ząbczyńska M, Korczak-Kowalska G, Lityńska A.

Anal Cell Pathol (Amst). 2015;2015:324980. doi: 10.1155/2015/324980. Epub 2015 Aug 3.

11.

Diverse expression of N-acetylglucosaminyltransferase V and complex-type β1,6-branched N-glycans in uveal and cutaneous melanoma cells.

Pocheć E, Rydlewska M, Przybyło M, Lityńska A.

Acta Biochim Pol. 2015;62(2):323-8. doi: 10.18388/abp.2015_1050. Epub 2015 Jun 22.

12.

Aberrant glycosylation of αvβ3 integrin is associated with melanoma progression.

Pocheć E, Bubka M, Rydlewska M, Janik M, Pokrywka M, Lityńska A.

Anticancer Res. 2015 Apr;35(4):2093-103.

PMID:
25862865
13.

The lectin-binding pattern of nucleolin and its interaction with endogenous galectin-3.

Hoja-Łukowicz D, Kedracka-Krok S, Duda W, Lityńska A.

Cell Mol Biol Lett. 2014 Sep;19(3):461-82. doi: 10.2478/s11658-014-0206-4. Epub 2014 Aug 29.

14.

Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.

Bubka M, Link-Lenczowski P, Janik M, Pocheć E, Lityńska A.

Biochimie. 2014 Aug;103:37-49. doi: 10.1016/j.biochi.2014.04.003. Epub 2014 Apr 13.

PMID:
24726881
15.

Studies on primary uveal and cutaneous melanoma cell interaction with vitronectin.

Janik ME, Lityńska A, Przybyło M.

Cell Biol Int. 2014 Aug;38(8):942-52. doi: 10.1002/cbin.10280. Epub 2014 Apr 28.

PMID:
24687613
16.

Expression of integrins α3β1 and α5β1 and GlcNAc β1,6 glycan branching influences metastatic melanoma cell migration on fibronectin.

Pocheć E, Janik M, Hoja-Łukowicz D, Link-Lenczowski P, Przybyło M, Lityńska A.

Eur J Cell Biol. 2013 Dec;92(12):355-62. doi: 10.1016/j.ejcb.2013.10.007. Epub 2013 Nov 1.

PMID:
24290991
17.

L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells.

Hoja-Łukowicz D, Link-Lenczowski P, Carpentieri A, Amoresano A, Pocheć E, Artemenko KA, Bergquist J, Lityńska A.

Glycoconj J. 2013 Apr;30(3):205-25. doi: 10.1007/s10719-012-9374-5. Epub 2012 Apr 29.

18.

Glycans in melanoma screening. Part 2. Towards the understanding of integrin N-glycosylation in melanoma.

Link-Lenczowski P, Lityńska A.

Biochem Soc Trans. 2011 Jan;39(1):374-7. doi: 10.1042/BST0390374.

PMID:
21265807
19.

Glycans in melanoma screening. Part 1. The role of β1,6-branched N-linked oligosaccharides in melanoma.

Przybyło M, Lityńska A.

Biochem Soc Trans. 2011 Jan;39(1):370-3. doi: 10.1042/BST0390370.

PMID:
21265806
20.

Cell migration-the role of integrin glycosylation.

Janik ME, Lityńska A, Vereecken P.

Biochim Biophys Acta. 2010 Jun;1800(6):545-55. doi: 10.1016/j.bbagen.2010.03.013. Epub 2010 Mar 20. Review.

PMID:
20332015
21.

Effect of alpha3beta1 and alphavbeta3 integrin glycosylation on interaction of melanoma cells with vitronectin.

Janik ME, Przybyło M, Pocheć E, Pokrywka M, Lityńska A.

Acta Biochim Pol. 2010;57(1):55-61. Epub 2010 Jan 11.

22.

Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients.

Vereecken P, Awada A, Suciu S, Castro G, Morandini R, Litynska A, Lienard D, Ezzedine K, Ghanem G, Heenen M.

Melanoma Res. 2009 Oct;19(5):316-20. doi: 10.1097/CMR.0b013e32832ec001.

PMID:
19581819
23.

The new face of nucleolin in human melanoma.

Hoja-Łukowicz D, Przybyło M, Pocheć E, Drabik A, Silberring J, Kremser M, Schadendorf D, Laidler P, Lityńska A.

Cancer Immunol Immunother. 2009 Sep;58(9):1471-80. doi: 10.1007/s00262-009-0705-8. Epub 2009 Apr 12.

PMID:
19363676
24.

Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin.

Baldwin G, Novitskaya V, Sadej R, Pochec E, Litynska A, Hartmann C, Williams J, Ashman L, Eble JA, Berditchevski F.

J Biol Chem. 2008 Dec 19;283(51):35445-54. doi: 10.1074/jbc.M806394200. Epub 2008 Oct 13.

25.

Characterisation of alpha3beta1 and alpha(v)beta3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines.

Kremser ME, Przybyło M, Hoja-Łukowicz D, Pocheć E, Amoresano A, Carpentieri A, Bubka M, Lityńska A.

Biochim Biophys Acta. 2008 Dec;1780(12):1421-31. doi: 10.1016/j.bbagen.2008.07.011. Epub 2008 Jul 29.

PMID:
18755246
26.
27.

Identification of proteins bearing beta1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis.

Przybyło M, Martuszewska D, Pocheć E, Hoja-Łukowicz D, Lityńska A.

Biochim Biophys Acta. 2007 Sep;1770(9):1427-35. Epub 2007 May 31.

PMID:
17600626
28.

Age effect on human aortic valvular glycoproteins.

Przybyło M, Stepień E, Pfitzner R, Lityńska A, Sadowski J.

Arch Med Res. 2007 Jul;38(5):495-502. Epub 2007 Apr 16.

PMID:
17560454
29.

Does glycosylation of melanoma cells influence their interactions with fibronectin?

Litynska A, Przybylo M, Pochec E, Kremser E, Hoja-Lukowicz D, Sulowska U.

Biochimie. 2006 May;88(5):527-34. Epub 2005 Dec 5.

PMID:
16380202
30.

Characterization of the oligosaccharide component of alpha3beta1 integrin from human bladder carcinoma cell line T24 and its role in adhesion and migration.

Pocheć E, Lityńska A, Bubka M, Amoresano A, Casbarra A.

Eur J Cell Biol. 2006 Jan;85(1):47-57. Epub 2005 Nov 8.

PMID:
16373174
31.

Characterization of glycosylation and adherent properties of melanoma cell lines.

Laidler P, Lityńska A, Hoja-Łukowicz D, Łabedz M, Przybyło M, Ciołczyk-Wierzbicka D, Pocheć E, Trebacz E, Kremser E.

Cancer Immunol Immunother. 2006 Jan;55(1):112-8. Epub 2005 Oct 27.

PMID:
16075194
32.
33.
34.

Characterization of the oligosaccharide component of microsomal beta-glucuronidase from rat liver.

Hoja-Łukowicz D, Butters TD, Lityńska A.

Biochimie. 2004 Jun;86(6):363-72.

PMID:
15358052
35.

Chemically-induced long-term potentiation in rat motor cortex involves activation of extracellular signal-regulated kinase cascade.

Grzegorzewska M, Przybylo M, Litynska A, Hess G.

Brain Res. 2004 Sep 24;1021(2):192-9.

PMID:
15342267
36.

The structure of the oligosaccharides of N-cadherin from human melanoma cell lines.

Ciołczyk-Wierzbicka D, Amoresano A, Casbarra A, Hoja-Łukowicz D, Lityńska A, Laidler P.

Glycoconj J. 2004;20(7-8):483-92.

PMID:
15316281
37.

Rat submandibular gland during the maturation process: changes in enzyme activities, protein and lectin-binding profiles.

Przybyło M, Lityńska A, Hoja-Łukowicz D, Kremser E.

Physiol Res. 2004;53(3):317-26.

38.

Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression.

Pocheć E, Lityńska A, Amoresano A, Casbarra A.

Biochim Biophys Acta. 2003 Dec 7;1643(1-3):113-23.

39.

Carbohydrate moieties of N-cadherin from human melanoma cell lines.

Ciołczyk-Wierzbicka D, Gil D, Hoja-Łukowicz D, Lityńska A, Laidler P.

Acta Biochim Pol. 2002;49(4):991-8.

40.
41.

The structure of the oligosaccharides of alpha3beta1 integrin from human ureter epithelium (HCV29) cell line.

Lityńska A, Pocheć E, Hoja-Lukowicz D, Kremser E, Laidler P, Amoresano A, Monti C.

Acta Biochim Pol. 2002;49(2):491-500.

42.

Different glycosylation of cadherins from human bladder non-malignant and cancer cell lines.

Przybylo M, Hoja-Lukowicz D, Litynska A, Laidler P.

Cancer Cell Int. 2002 Jun 18;2:6.

43.

Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.

Laidler P, Gil D, Pituch-Noworolska A, Ciołczyk D, Ksiazek D, Przybyło M, Lityńska A.

Acta Biochim Pol. 2000;47(4):1159-70.

44.

Comparison of the lectin-binding pattern in different human melanoma cell lines.

Lityńska A, Przybyło M, Pocheć E, Hoja-Łukowicz D, Ciołczyk D, Laidler P, Gil D.

Melanoma Res. 2001 Jun;11(3):205-12.

PMID:
11468508
45.

Affinity chromatography of branched oligosaccharides in rat liver beta-glucuronidase.

Hoja-Lukowicz D, Lityńska A, Wójczyk BS.

J Chromatogr B Biomed Sci Appl. 2001 May 5;755(1-2):173-83.

PMID:
11393703
46.

Differences of alpha3beta1 integrin glycans from different human bladder cell lines.

Lityńska A, Przybyło M, Ksiazek D, Laidler P.

Acta Biochim Pol. 2000;47(2):427-34.

48.

High-mannose-type oligosaccharides from human placental arylsulfatase A are core fucosylated as confirmed by MALDI MS.

Hoja-Lukowicz D, Ciołczyk D, Bergquist J, Lityńska A, Laidler P.

Glycobiology. 2000 Jun;10(6):551-7.

PMID:
10814696
49.

Changes in glycosylation of rat liver arylsulfatase B in relation to age.

Przybyło M, Lityńska A.

Mech Ageing Dev. 2000 Feb 15;113(3):193-203.

PMID:
10714938
50.

Age-related profile of beta-N-acetylhexosaminidase glycosylation in rat liver.

Lityńska A, Przybyło M.

Acta Biochim Pol. 1998;45(3):791-7.

Supplemental Content

Loading ...
Support Center